Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: MicroRNA-based integrated diagnosis and therapy for GBM: current status and advances.

Frontiers in immunology·2026
Same author

Scleral image analysis via artificial intelligence to evaluate inflammatory status in inflammatory bowel disease.

International journal of colorectal disease·2026
Same author

Layered Copper-Anthraquinone Coordination Polymer Cathode Leveraging Dual-Redox Sites and Facilitated Ion Diffusion for High-Performance Lithium-Ion Batteries.

Angewandte Chemie (International ed. in English)·2026
Same author

Dose-dependent mortality risk of plasma transfusion in critically ill patients.

Hematology, transfusion and cell therapy·2026
Same author

A competitive endogenous RNA network involving RiLinc6978 and miR9474-5p regulates fruit softening in tomato.

The Plant cell·2026
Same author

Association of leuko-glycemic index with mortality in ICU patients with Acute kidney injury: A retrospective multicenter cohort study.

PloS one·2026

Related Experiment Video

Updated: Jul 11, 2025

Fat-Covered Islet Transplantation Using Epididymal White Adipose Tissue
06:39

Fat-Covered Islet Transplantation Using Epididymal White Adipose Tissue

Published on: May 25, 2021

2.1K

Subcutaneous device-free islet transplantation.

Xudong Zhou1, Zhiran Xu2, Yanqiu You2

  • 1Guangxi University, Nanning, China.

Frontiers in Immunology
|November 15, 2023
PubMed
Summary

Subcutaneous islet transplantation offers a simpler, safer alternative for Type 1 diabetes mellitus (T1DM) management. Advanced bioengineering and biomaterials improve graft survival, reducing the burden of lifelong insulin therapy.

Keywords:
diabetes mellitusextracellular matrixextracellular matrix diabetes mellitushydrogelislet viability matrixsubcutaneous islet transplantation

More Related Videos

Inguinal Subcutaneous White Adipose Tissue ISWAT Transplantation Model of Murine Islets
10:14

Inguinal Subcutaneous White Adipose Tissue ISWAT Transplantation Model of Murine Islets

Published on: February 16, 2020

6.4K
Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice
11:57

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Published on: July 23, 2017

10.1K

Related Experiment Videos

Last Updated: Jul 11, 2025

Fat-Covered Islet Transplantation Using Epididymal White Adipose Tissue
06:39

Fat-Covered Islet Transplantation Using Epididymal White Adipose Tissue

Published on: May 25, 2021

2.1K
Inguinal Subcutaneous White Adipose Tissue ISWAT Transplantation Model of Murine Islets
10:14

Inguinal Subcutaneous White Adipose Tissue ISWAT Transplantation Model of Murine Islets

Published on: February 16, 2020

6.4K
Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice
11:57

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Published on: July 23, 2017

10.1K

Area of Science:

  • Endocrinology
  • Regenerative Medicine
  • Surgical Innovation

Background:

  • Type 1 diabetes mellitus (T1DM) affects over 500 million globally, necessitating lifelong insulin therapy with significant economic and patient burden.
  • Current islet transplantation into the hepatic portal vein faces challenges due to inflammatory and immune responses.
  • Subcutaneous islet transplantation presents a simpler, lower-risk alternative with advantages in monitoring and graft retrieval.

Purpose of the Study:

  • To review current device-free subcutaneous islet transplantation methods for Type 1 diabetes mellitus (T1DM).
  • To highlight advancements in bioengineering and biomaterials enhancing subcutaneous islet graft success.
  • To assess the potential of these techniques in improving T1DM management.

Main Methods:

  • Review of recent literature on subcutaneous islet transplantation techniques.
  • Focus on device-free approaches utilizing bioengineering and biomaterial co-transplantation.
  • Examination of methods including cell/growth factor co-transplantation and hydrogel/simulated ECM encapsulation.

Main Results:

  • Recent techniques demonstrate high success rates in subcutaneous islet transplantation.
  • Bioengineering and biomaterial strategies significantly improve post-transplantation graft survival.
  • Device-free modalities simplify surgical procedures compared to traditional methods.

Conclusions:

  • Subcutaneous islet transplantation is a viable and improving alternative for T1DM.
  • Advanced co-transplantation and encapsulation techniques enhance graft efficacy and survival.
  • These innovations offer a promising pathway for more effective T1DM management, potentially reducing reliance on insulin injections.